Paul Fernyhough Selected Research

Paul Fernyhough Research Topics

Disease

15	Mitochondrial Diseases (Mitochondrial Disease) 11/2022 - 07/2008
12	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 06/2008
11	Diabetic Neuropathies (Diabetic Neuropathy) 03/2024 - 01/2002
7	Hyperglycemia 03/2022 - 01/2002
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 06/2008
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 01/2008
4	Infections 08/2015 - 01/2011
2	Pain (Aches) 03/2024 - 06/2008
2	Hyperalgesia 03/2024 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 11/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2007
1	Overactive Urinary Bladder (Overactive Bladder) 03/2024
1	Nerve Degeneration 11/2022
1	Neuroblastoma 11/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2022
1	Huntington Disease (Huntington's Disease) 01/2021
1	Reperfusion Injury 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2020
1	Genomic Instability 12/2019
1	Central Nervous System Diseases (CNS Diseases) 11/2019
1	Major Depressive Disorder (Major Depressive Disorders) 11/2019
1	Cognitive Dysfunction 11/2019
1	Polyneuropathies (Polyneuropathy) 11/2018
1	Encephalitis (Encephalitis, Rasmussen) 10/2017
1	Diabetes Mellitus 01/2017
1	Septic Shock (Toxic Shock Syndrome) 12/2016
1	Neoplasms (Cancer) 12/2014
1	Necrosis 12/2014
1	Heart Failure 12/2014

Drug/Important Bio-Agent (IBA)

6	Insulin (Novolin)FDA Link 01/2019 - 08/2003
4	Muscarinic AntagonistsIBA 03/2024 - 02/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2010
4	NAD (NADH)IBA 12/2019 - 06/2008
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 03/2024 - 02/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 12/2014
3	AMP-Activated Protein KinasesIBA 06/2020 - 03/2013
3	Streptozocin (Streptozotocin)FDA Link 01/2020 - 11/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2008
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2022 - 06/2020
2	Cholinergic Agents (Cholinergics)IBA 11/2022 - 06/2020
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2013
2	Phosphotransferases (Kinase)IBA 11/2020 - 01/2002
2	PirenzepineIBA 01/2020 - 02/2017
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 11/2015
2	polyolIBA 11/2018 - 08/2003
2	AntioxidantsIBA 10/2017 - 01/2011
2	CalciumIBA 11/2014 - 02/2010
2	Protein Kinases (Protein Kinase)IBA 06/2012 - 01/2002
1	oxybutynin (Tavor)FDA LinkGeneric 03/2024
1	Aldehyde Reductase (Aldose Reductase)IBA 03/2022
1	Insulin-Like PeptidesIBA 03/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2022
1	sorbinilIBA 03/2022
1	Superoxides (Superoxide)IBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	CreatineIBA 11/2020
1	ibrutinibIBA 03/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	Poly (ADP-Ribose) Polymerase-1IBA 12/2019
1	EnzymesIBA 12/2019
1	NSI-189IBA 11/2019
1	Sirtuin 2IBA 11/2018
1	Amyloid (Amyloid Fibrils)IBA 10/2017
1	HIV Envelope Protein gp120IBA 02/2017
1	muscarinic toxin 7IBA 02/2017
1	N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA 02/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2017
1	SodiumIBA 12/2016
1	SaltsIBA 12/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016
1	2,5-dihydroxybenzoic acid (gentisic acid)IBA 12/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2016
1	PhosphoproteinsIBA 08/2015
1	Mitochondrial Permeability Transition PoreIBA 12/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014
1	Protons (Proton)IBA 12/2013
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 12/2013
1	CytokinesIBA 10/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2013
1	Ciliary Neurotrophic Factor (CNTF)IBA 02/2013
1	DNA (Deoxyribonucleic Acid)IBA 02/2013
1	Peptides (Polypeptides)IBA 08/2012
1	Adenosine Monophosphate (AMP)IBA 06/2012
1	Adenosine Triphosphatases (ATPase)IBA 01/2012
1	UbiquinoneIBA 01/2011
1	Cysteine (L-Cysteine)FDA Link 01/2011
1	ProteomeIBA 01/2011
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2010

Therapy/Procedure

6	Therapeutics 01/2021 - 08/2003
3	Drug Therapy (Chemotherapy) 06/2020 - 12/2014
1	Subcutaneous Injections 01/2020
1	Glycemic Control 11/2019